MPEP § 2401 — Introduction (Annotated Rules)
§2401 Introduction
This page consolidates and annotates all enforceable requirements under MPEP § 2401, including statutory authority, regulatory rules, examiner guidance, and practice notes. It is provided as guidance, with links to the ground truth sources. This is information only, it is not legal advice.
Introduction
This section addresses Introduction.
Key Rules
Sequence Listing Content
This chapter provides guidance on the practices and procedures pertaining to the rules for deposits of biological materials for patent purposes (37 CFR 1.801 – 1.809) and the rules for the requirements for patent applications containing nucleotide sequence and/or amino acid sequence disclosures under World Intellectual Property Organization (WIPO) Standard ST.25 (37 CFR 1.821 – 1.825) and WIPO Standard ST.26 (37 CFR 1.831 – 1.835).
Citations
| Primary topic | Citation |
|---|---|
| Sequence Listing Content | 37 CFR § 1.801 |
| Sequence Listing Content | 37 CFR § 1.821 |
| Sequence Listing Content | 37 CFR § 1.831 |
Source Text from USPTO’s MPEP
This is an exact copy of the MPEP from the USPTO. It is here for your reference to see the section in context.
Official MPEP § 2401 — Introduction
Source: USPTO2401 Introduction [R-01.2024]
This chapter provides guidance on the practices and procedures pertaining to the rules for deposits of biological materials for patent purposes (37 CFR 1.801 – 1.809) and the rules for the requirements for patent applications containing nucleotide sequence and/or amino acid sequence disclosures under World Intellectual Property Organization (WIPO) Standard ST.25 (37 CFR 1.821 – 1.825) and WIPO Standard ST.26 (37 CFR 1.831 – 1.835).